Healthcare & Life Sciences Professionals |
Moving up the Biotechnology value chain |
IT Services - Healthcare |
18 more ...
New Drugs Value Creation
Tags :
new drugs, new drug, prescription drugs, generic drugs, drugs, medication, intellectual property, patent, biotechnology, biotech, patent law, pharmaceutical industry,
Industry :
Biotechnology
Functional Area : Innovation, new technologies |
|
|
Follow this Topic |
more actions >>
|
The past two decades were a period of rapid development of new drug treatments for various diseases. For many patients, the new medications represent advances over existing drugs with respect to efficacy and side effects, and are generally easier for physicians to administer. Some believe these new drugs have brought about revolutionary changes in the treatment of diseases. At the same time, the growth in psychotropic drug costs has been explosive. Rapid cost increases combined with high accounting profits have brought increased scrutiny to drug manufacturers over whether the drugs they produce are worth the costs. Industry critics argue that while some medications have been genuine breakthrough drugs like the first SSRIs, such as Prozac, drugs and product reformulations have resulted in only modest treatment changes because of their similarity to existing drugs. So let us discuss on this topic....
|
(rate this)
|
|
Yes
|
9
|
VS |
5
|
No
|
|
|
Navnath K. Bodke
| Argues in support of
"Yes"
| 3 years ago
|
|
yes, we can replace animal studies with in-vitro studies but there are limitations like we can not test antiepileptic effects or antipsychotic effect. all we can do it that try to reduce the use of animals for that we should knpw the 4R consept
|
|
|
|
Anindya Basu
| Argues in support of
"No"
| 4 years ago
|
|
I agree that ATC techniques has made tremendous advances in the recent past, even chip technologies have been devised to evaluate the drug actions, however, the simulation of the entire body using these techniques is still far away at the present...
|
|
|
|
Agalya Priyadarshni.K
| Argues in support of
"Yes"
| 4 years ago
|
|
Well ACC techniques are a boon in clinical reaearch. Reasons include: 1. Animal usage for testing is reduced though cannot be completely avoided. 2. Provide a platform for preliminary testings of the drug so that confirmed effective drugs in the...
|
|
|
(rate this)
|
|
|
Rajesh Kumar Mahato
| Answered
| 3 years ago
|
|
Today we know, life is specified by genome and genome is specified by DNA. Thus, with complete genomic information using reverse vaccinology a new novel gene can be identified which might be the potential to cause disease. Using Genomics and...
|
|
|
|
BEENA AGARWAL
| Answered
| 4 years ago
|
|
I agree with Narayana as both the technologies has got their specific impact in drug discovery by all means.Its fact that today these two basic term has got prime importance for basic reasearches in drug discovery and drug manufaturing too.
|
|
|
(rate this)
|
|
|
Mustafa Mahedvi
| Supported idea
"Integration of complex and disconnected data sets."
| 4 years ago
|
|
Yeah a ot of data right from the R D stage has to be generated, it involves lot of effort and money. Sharing of data within commercial establishment is not possible due to secrecy clause and the ongoing competition. The academia must be invoved...
|
|
|
|
Bindu Narayan
| Supported idea
"Drug Discovery Approach"
| 4 years ago
|
|
I agree to you, drugs are tested at molecular level in vitro and then when actually tested on human body they fail. Because human body has many more complications affecting the same process..
|
|
|
(rate this)
|
|
|
Ajoy Mondal
| Answered
| 5 years ago
|
|
The clinical investigation of a previously untested drug is generally divided into three phases. Although in general the phases are conducted sequentially, they may overlap. The three phases of an investigation are as follows: Phase 1; includes...
|
|
|
|
Bindu Narayan
| Answered
| 4 years ago
|
|
Thousands of chemicals, both synthetic and extracted from "natural" sources, are being examined in the hope of finding new drugs with which to combat human and veterinary diseases. The first step is to use laboratory tests to find if these...
|
|
|
(rate this)
|
|
Yes
|
6
|
VS |
9
|
No
|
|
|
Narendran Subramanaian
| Argues in support of
"No"
| 4 years ago
|
|
No, This will lead people to consume these drugs with out a proper diagonosis and with wrong dosage resulting to insane to that medicine and other side effects.
|
|
|
|
varsha
| Argues in support of
"Yes"
| 4 years ago
|
|
yes i am in favor of advertizing prescription directly to public. thanks
|
|
|
(rate this)
|
|
(rate this)
|
|
|
V kumar
| Answered
| 2 years ago
|
|
Animal testing can have many different effects on an animal depending on the species, but these are the most common: 1. Loss of life 2. Impared hearing or other senses or complete loss of them 3. Impared movement 4. May cause the animal not able...
|
|
|
|
Moparthi Sai Ramya Sree
| Answered
| 2 years ago
|
|
it destroys the general eco system the experiments must be in such a way that they won't destroy the habitat
|
|
|
|
Rajendra K Labala
| Answered
| 4 years ago
|
|
We can use bioinformatics protocols or in-silico techniques to minimize the animal testing. Yes, I know at every place its not an easy idea to apply but its not impossible...!!!
|
|
|
(rate this)
|
|
|
Bindu Narayan
| Added idea
"A heart rhythm disorder.."
| 4 years ago
|
|
A new computer system has been described in the November/December issue of the ACS's bi-monthly Journal of Chemical Information and Modeling.It will detect a heart rhythem disorder with high accuracy and predict the mishaps.. Such screening will...
|
|
|
(rate this)
|
|
Yes
|
10
|
VS |
3
|
No
|
|
|
sneha shukla
| Argues in support of
"Yes"
| 3 years ago
|
|
definately, plants r not going to serve but r serving as "organic factories".there is no two ways about it.the GM crops are already known by all.ofcorse the GM crops have risks associated with it but as d rule says-"no risks,no gains".afterall...
|
|
|
|
Kaushik Dutta
| Argues in support of
"No"
| 3 years ago
|
|
Genetically modified crops have generated much public interest and controversy. Scientific information available today is not adequate to draw conclusive deductions on the potential benefits or risks of the genetically modified plants to the...
|
|
|
|
Tipirneni Sridhar
| Argues in support of
"No"
| 4 years ago
|
|
Though plants can be used for manufacturing of biopharmaceuticals on an economic platform, the intricacies involved (with respect to genetic engineering procedures and adaptability of the transgenics) are hindering the process. As we can see from...
|
|
|
(rate this)
|
|
Yes
|
1
|
VS |
0
|
No
|
|
|
Bindu Narayan
| Argues in support of
"Yes"
| 4 years ago
|
|
In the wake of several notorious drug withdrawals caused by unsuspected toxicities, pharmaceutical companies are searching for ways to minimize the escalating risks and costs of drug development. Biomarkers of toxicity offer the hope of producing...
|
|
|
Activity:
85 referals
,
18 comments,
243 views
|
|
|
"2 bananas cost 50 cents, banana dessert costs 10 dollars" Marketing is story-telling of any selling proposition beyond the obvious. A grand chef can change the total perception, price and taste of 2 bananas by infusing value in them through his skill. Two bananas cost 50 cents. But the same simple bananas can be transformed into a terrific dessert costing anywhere from $10 to $50 depending on the chef’s reputation. His repute gets built over time from his proven quality and taste he conjures up that his guests perceive and regard highly. Marketing is exposing the excellence of the banana dessert the chef creates by transforming two basic bananas. Of course, the dessert has to have truth and ingenuity that end-customers can recognize and take seriously. End-customers have to believe in that dessert and its quality excellence, it must work well for them, and it must look good. This is what marketing is. You can read the complete article here. What do you think?...
|
|
Activity:
177 referals
,
16 comments,
210 views
|
|
|
What Indian Business Education don’t provide for the Environment. Value generated and transacted in Business is the hallmark and pillar of the skill generated from a Business education. A business when it sell products in India, they don’t worry about the affordability of their wares by the masses let alone functionality which may be part of it. A business incurs around 40% of fixed cost component along with may be 30% variable cost and probably the rest as ‘conversion cost’. What Business education teach us and what is followed in Efficient economies is they fix a breakeven point say 100 units of sale. These 100 units will provide the years cost incurred. After this point they will start giving discounts say 10% or so, so that more of products will move at lowered costs. If products are priced far above these three costs then the demand will subside and the production line will stagnate even for normal production. Two things are required in the environment for this process to...
|

|
|
|
|
|
|